Diyabette Yeni Çağ: Solunan İnsülin, 1 Yıllık Sensör ve Yapay Pankreas | Doç. Dr. Halis Kaan Aktürk

Today on the Ok But First Insulin channel, we're discussing the current state of diabetes technologies and what the future holds. My guest is Assoc. Prof. Dr. Halis Kaan Aktürk from the Barbara Davis Diabetes Center. He is a leading figure in diabetes technologies, artificial pancreas systems, continuous glucose monitoring systems, and next-generation insulin therapies. In this episode, we're exploring the question, "Has the future of diabetes arrived?" Some of the topics we discuss in the video include: 🔹 The difference between receiving a diabetes diagnosis 20 years ago and today 🔹 The importance of early sensor use in newly diagnosed patients 🔹 Is diabetes management possible without finger pricking? 🔹 Do artificial pancreas systems really think for us? 🔹 Could carbohydrate counting one day be completely eliminated? 🔹 Can artificial intelligence independently adjust insulin doses? 🔹 What do sensors that remain in the body for a year mean? 🔹 Can inhaled insulin replace the Afrezza injection? 🔹 When will weekly insulins become a part of our lives? 🔹 Can medications like Ozempic/Semaglutide be used in Type 1 diabetes? 🔹 Why are diabetes technologies still not accessible to everyone? This episode isn't just an interview where we talk about technology; it's also a powerful conversation about hope, access, science, and the future for individuals living with diabetes. If you want to see more content about type 1 diabetes, sensors, insulin pumps, artificial pancreas systems, and diabetes technologies, don't forget to subscribe to the channel. 💬 Which technology are you most curious about? Inhaled insulin, a one-year sensor, or an artificial pancreas? Let's meet in the comments. #OkButFirstInsulin #Type1Diabetes #DiabetesTechnologies #ArtificialPancreas #InhaledInsulin #CGM #InsulinPump